HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Groot Selected Research

AN 215

4/2002Effective treatment of experimental U-87MG human glioblastoma in nude mice with a targeted cytotoxic bombesin analogue, AN-215.
11/2000In vivo inhibition of PC-3 human androgen-independent prostate cancer by a targeted cytotoxic bombesin analogue, AN-215.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Groot Research Topics

Disease

14Neoplasms (Cancer)
01/2004 - 01/2000
5Carcinoma (Carcinomatosis)
02/2004 - 11/2000
3Prostatic Neoplasms (Prostate Cancer)
02/2004 - 07/2000
3Breast Neoplasms (Breast Cancer)
10/2001 - 03/2000
3Pancreatic Neoplasms (Pancreatic Cancer)
06/2001 - 01/2000
2Ovarian Neoplasms (Ovarian Cancer)
11/2001 - 09/2001
1Pituitary Neoplasms (Pituitary Adenoma)
11/2002
1Osteosarcoma (Osteogenic Sarcoma)
10/2002
1Ewing Sarcoma (Sarcoma, Ewing)
10/2002
1Sarcoma (Soft Tissue Sarcoma)
10/2002
1Glioblastoma (Glioblastoma Multiforme)
04/2002
1Glioma (Gliomas)
04/2002
1Neoplasm Metastasis (Metastasis)
10/2001
1Carcinogenesis
10/2001
1Ovarian Epithelial Carcinoma
05/2001
1Colonic Neoplasms (Colon Cancer)
05/2000
1Colorectal Neoplasms (Colorectal Cancer)
05/2000
1Leukopenia
02/2000

Drug/Important Bio-Agent (IBA)

10Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA
02/2004 - 01/2000
10Messenger RNA (mRNA)IBA
10/2002 - 01/2000
6BombesinIBA
01/2004 - 03/2000
5Gastrin-Releasing PeptideIBA
01/2004 - 03/2000
5Insulin-Like PeptidesIBA
01/2004 - 01/2000
5Insulin-Like Growth Factor II (Somatomedin A)IBA
11/2001 - 01/2000
5Insulin-Like Growth Factor I (IGF-1)IBA
10/2001 - 01/2000
4JV 1-36IBA
11/2001 - 05/2001
4Estrogens (Estrogen)FDA Link
10/2001 - 02/2000
3AndrogensIBA
02/2004 - 07/2000
3Hormones (Hormone)IBA
02/2004 - 02/2000
3JV 1-38IBA
02/2004 - 07/2000
3Gonadotropin-Releasing Hormone (GnRH)FDA Link
02/2004 - 02/2000
3Hca(6)-Leu(13)-psi(CH2N)-Tac(14)- bombesin(6-14)IBA
01/2004 - 03/2000
3Tpi(6)-Leu(13)-psi(CH2NH)-Leu(14)- bombesin (6-14)IBA
01/2004 - 03/2000
3somatotropin releasing hormone receptorIBA
11/2002 - 05/2001
3Peptides (Polypeptides)IBA
04/2002 - 02/2000
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2001 - 03/2000
3Epidermal Growth Factor (EGF)IBA
09/2001 - 03/2000
3MZ 5-156IBA
05/2001 - 01/2000
2AN 215IBA
04/2002 - 11/2000
2Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
11/2001 - 06/2000
2AN 204 (AN 201)IBA
11/2000 - 02/2000
2ErbB Receptors (EGF Receptor)IBA
07/2000 - 03/2000
1Triptorelin Pamoate (Trelstar)FDA Link
02/2004
1Flutamide (Eulexin)FDA LinkGeneric
02/2004
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
01/2004
1Matrix Metalloproteinases (MMPs)IBA
01/2004
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2004
1ProlactinIBA
11/2002
1Protein Isoforms (Isoforms)IBA
10/2002
1Methylnitronitrosoguanidine (MNNG)IBA
10/2002
1Doxorubicin (Adriamycin)FDA LinkGeneric
04/2002
1Bombesin Receptors (Bombesin Receptor)IBA
04/2002
1JV 1-52IBA
11/2001
1LigandsIBA
10/2001
1neuromedin BIBA
09/2001
1cetrorelix (Cetrotide)FDA Link
09/2001
1RNA (Ribonucleic Acid)IBA
05/2001
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
05/2001
1vapreotideIBA
05/2001
1Carboxylic Ester HydrolasesIBA
11/2000
1bombesin receptor subtype 3IBA
11/2000
1EstersIBA
11/2000
1NeuropeptidesIBA
07/2000
1AN 207IBA
02/2000
1Membrane Proteins (Integral Membrane Proteins)IBA
02/2000
1nucleolar organizer region associated proteinsIBA
01/2000
1MZ 4-71IBA
01/2000

Therapy/Procedure

7Therapeutics
02/2004 - 01/2000
3Drug Therapy (Chemotherapy)
04/2002 - 02/2000
2Aftercare (After-Treatment)
11/2000 - 02/2000